Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non‐diabetic exosomes in vitro

Many patients with ischaemic heart disease also have diabetes. As myocardial infarction is a major cause of mortality and morbidity in these patients, treatments that increase cell survival in response to ischaemia and reperfusion are needed. Exosomes—nano‐sized, lipid vesicles released from cells—c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cell Mol Med
Asıl Yazarlar: Davidson, Sean M., Riquelme, Jaime A., Takov, Kaloyan, Vicencio, Jose M., Boi‐Doku, Claire, Khoo, Vanessa, Doreth, Christian, Radenkovic, Dina, Lavandero, Sergio, Yellon, Derek M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5742744/
https://ncbi.nlm.nih.gov/pubmed/28840975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13302
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller